511 filings
Page 3 of 26
8-K
grtishj4uah7xj
30 May 23
Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors
4:32pm
8-K
jpvkhpayri
10 May 23
Catalyst Pharmaceuticals Reports Record First Quarter 2023 Results, Achieving
4:47pm
8-K
s7lew3h13q3go8z
9 May 23
Other Events
8:43am
8-K/A
kil uostxlgow23
10 Apr 23
Financial Statements and Exhibits
4:30pm
8-K
bh8e70 v3gh3557prako
31 Mar 23
Departure of Directors or Certain Officers
4:45pm
8-K
0kzsh22c9bv
15 Mar 23
Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2022
4:41pm
8-K
aa4b2ca
7 Mar 23
Other Events
4:40pm
8-K
ocvlutd0n34ge 0pkb
7 Feb 23
Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 Total Revenues and Provides Full Year 2023 Revenue Guidance
8:19am
8-K
xys2seva
30 Jan 23
Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
4:15pm
8-K
ccru9xgv7s qp3gh5
24 Jan 23
Other Events
4:30pm
8-K
0a5tvx
23 Jan 23
Other Events
8:25am
8-K
5fnnv qxyrv1
22 Dec 22
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
4:31pm
8-K
pew mu4ab
9 Nov 22
Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update
4:32pm
8-K
3229p tahfpc
29 Sep 22
Other Events
4:30pm
8-K
oyhvyqeqwmacf0mlo0
19 Sep 22
Departure of Directors or Certain Officers
5:28pm
8-K
7gh5fri
9 Sep 22
Departure of Directors or Certain Officers
4:30pm